Standard |
Ovarian transposition/oophoropexy102,103
|
Surgery is performed to move the ovaries and fallopian tubes out of the radiation field |
|
• |
|
|
• |
|
Only protects against pelvic irradiation
Will not prevent natural ovarian aging from occurring
Does not protect the uterus
|
Gonadal shielding104
|
Shielding is used to minimize the exposure of reproductive organs to radiation |
|
• |
|
|
• |
|
Only protects against irradiation |
Embryo cryopreservation46
|
Hyperstimulation protocols are used to recruit multiple follicles to enter the growth phase
Ovulation is triggered and mature eggs are aspirated
Eggs are fertilized by IVF or ICSI – Embryos are cryopreserved
|
• |
|
• |
• |
|
|
|
Investigational |
Egg cryopreservation46,55
|
Hyperstimulation protocols are used to recruit multiple follicles to enter the growth phase
Once multiple antral follicles are obtained, ovulation is triggered and mature eggs are aspirated
Eggs are cryopreserved
|
• |
|
• |
|
|
• |
Will delay cancer treatment up to 2–5 weeks
Is becoming a viable reproductive technology
Maintains the reproductive autonomy of the patient
Requires ICSI/IVF post-thaw
|
Oocyte cryopreservation105
|
|
• |
|
• |
|
|
• |
Will delay cancer treatment up to 2–5 weeks
Is less effective than egg cryopreservation
Requires IVM post-thaw
Requires ICSI/IVF post-thaw
|
Isolation of an oocyte or an egg from a natural cycle106
|
|
|
• |
|
|
|
• |
Only results in one oocyte or egg from a natural cycle and takes approximately 2–10 days
Is risky for cancer patients who only have one chance
Requires cryopreservation
Requires IVM if an oocyte is aspirated pre-cryopreservation or post-thaw
Requires ICSI/IVF pre-cryopreservation or post-thaw
|
Isolation of oocytes from an ovarian biopsy107
|
Oocytes are harvested from an ovarian biopsy |
|
• |
|
|
|
• |
Can be performed at any stage of the menstrual cycle
Requires cryopreservation
Requires IVM pre-cryopreservation or
Requires ICSI/IVF pre-cryopreservation or post-thaw
|
Ovarian tissue cryopreservation followed by transplantation60,61,108
|
Ovarian tissue is removed and cryopreserved
Following cancer treatment, thawed tissue can be autografted (orthotopic or heterotopic)
|
|
• |
|
|
• |
|
Can be performed at any stage of the menstrual cycle
Can be done with whole ovaries or cortical strips
Has the potential to reintroduce cancerous cells
Has a limited lifetime
|
Ovarian hormonal suppression109
|
Patients are treated with gonadotrophin- releasing hormone analogs (GnRH) or oral contraceptives to keep the ovary in a hypogonadotropic environment |
|
• |
|
|
• |
|
|
In Development |
Ovarian tissue cryopreservation followed by in vitro follicle growth70–72,108,110
|
Ovarian tissue is removed and cryopreserved
Following cancer treatment, follicles can be isolated from thawed ovarian tissue and grown in vitro
|
|
• |
|
|
|
• |
Can be performed at any stage of the menstrual cycle
Avoids the risk for reintroducing cancerous cells
Requires IVM
Requires ICS/IVF
Is still being optimized for in vitro growth of primordial and primary follicles
|
Follicle isolation and cryopreservation72,111
|
|
|
• |
|
|
|
• |
Can be performed at any stage of the menstrual cycle
Avoids the risk for reintroducing cancerous cells
Requires in vitro follicle growth post-thaw
Requires IVM post-thaw
Requires ICSI/IVF post-thaw
Could be used for transplant
|
Transplantation of isolated follicles112
|
Follicles are isolated from fresh or thawed ovarian tissue
Following cancer treatment, follicles can be transplanted into the patient
|
|
• |
|
|
• |
|
|
Xenotransplantation of ovarian tissue or follicles113–116
|
Ovarian tissue is removed and either cryopreserved or used to isolate follicles that are cryopreserved.
Following cancer treatment, thawed tissue or follicles can be transplanted into a host that supports follicular growth and development
|
|
• |
|
|
|
• |
|
Use of fertoprotective drugs117,118
|
Novel chemotherapeutics whose delivery mode is less gonadotoxic (ex. nanobins; our unpublished results) |
|
|
|
|
• |
|
|
Non-biological/Third Party |
Egg or embryo donor |
Following cancer treatment, a patient can obtain donor eggs or embryos
Following relevant ART procedures, embryos can be transferred back to the patient’s own uterus or to a surrogate uterus
|
|
|
|
|
|
|
|
Surrogate |
Following cancer treatment, patient embryos are thawed and transferred to a surrogate
Following cancer treatment, patient oocytes or eggs are thawed and ART procedures are performed (IVM/IVF/ICSI); embryos are transferred to a surrogate
|
|
|
|
|
|
|
Bypasses pregnancy complications due to uterine dysfunction
Assumes that cryopreserved material is developmentally competent
Can also be used if patient’s fertility was not compromised by cancer treatment
Can be a very high cost for the patient
|
Adoption119
|
Patients can adopt a non-biological child (children) |
|
|
|
|
|
|
|